Amyloid beta 42 (Abeta42) Antibody
260€ (100 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Amyloid beta 42 (Abeta42) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx175370
tested applications
WB, IHC, IF/ICC
Description
Amyloid beta 42 (Abeta42) Antibody is a Rabbit Polyclonal antibody against Amyloid beta 42 (Abeta42).
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Amyloid beta 42 (Abeta42) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Size 1 | 100 µl |
| Size 2 | 200 µl |
| Size 3 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Shipped within 5-7 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P05067 |
| Alias | Aβ42|Amyloid Beta 42|Aβ|1-42|Aβ1-42 |
| Background | Antibody anti-Abeta42 |
| Status | RUO |
Descripción
Abeta42 is a 42-amino acid peptide that differs from Aβ40 by two additional residues at the C-terminal end, resulting in increased hydrophobicity and a greater propensity to aggregate into oligomers and fibrils. Aβ42 is a major component of the amyloid plaques found in Alzheimer’s disease, playing a critical role in its pathogenesis. Its aggregation disrupts neuronal membranes, induces oxidative stress, and triggers inflammatory responses, leading to synaptic dysfunction and neuronal death. Aβ42 is considered more neurotoxic than Aβ40 due to its higher aggregation potential and its ability to form soluble oligomers that impair synaptic signaling. The ratio of Aβ42 to Aβ40 in cerebrospinal fluid is a key biomarker for diagnosing and monitoring Alzheimer’s disease progression. Research is ongoing to understand the mechanisms of Aβ42 aggregation and its interactions with tau proteins, with the goal of developing therapeutic strategies targeting Aβ42 to mitigate Alzheimer’s-related neurodegeneration.
Related Products
Mouse Aβ40(Amyloid Beta 40) ELISA Kit
Ver Producto
Human Amyloid beta 42 (Abeta42) CLIA Kit
Human Amyloid beta 42 (Abeta42) Chemiluminescent Immunoassay (CLIA) Kit is a Chemiluminescent Immunoassay (CLIA) kit against Amyloid beta 42 (Abeta42).
Ver Producto
Amyloid Beta Peptide 1-17 (Ab1-17) Antibody
Amyloid Beta Peptide 1-17 (Ab1-17) Antibody is a Mouse Monoclonal antibody against BETA AMYLOID.
Ver Producto